Healthcare Services

Enzyme-Linked Immunosorbent Assay Testing Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Enzyme-Linked Immunosorbent Assay Testing Market Over The Period 2026–2030?

The enzyme-linked immunosorbent assay testing market has seen strong growth in recent years. It is anticipated to expand from $3.04 billion in 2025 to $3.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. The historical growth of this market can be attributed to the widespread use of ELISA in diagnostic testing, the increasing scope of biomedical research activities, the rising prevalence of infectious and chronic diseases, a growing dependence on immunoassays, and the availability of standardized testing protocols.

The market for enzyme-linked immunosorbent assay (ELISA) testing is projected to experience robust expansion in the coming years. This market is anticipated to reach $4.12 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.2%. This growth during the projection period stems from several factors, including the rising embrace of automated laboratory processes, an escalating need for biomarker-driven diagnostics, the broadening of ELISA applications within oncology and immunology, a heightened emphasis on the early detection of diseases, and increased funding for clinical research infrastructure. Key trends foreseen for this period encompass a greater uptake of high-throughput ELISA platforms, an increasing requirement for multiplex immunoassays, the expanding integration of automated sample processing, a wider application of ELISA in clinical research, and a sharpened focus on the sensitivity and accuracy of assays.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19417&type=smp

What Drivers Are Expected To Influence The Enzyme-Linked Immunosorbent Assay Testing Market During The Forecast Period?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the enzyme-linked immunosorbent assay testing market in the future. These disorders are illnesses stemming from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, capable of transmission between people and affecting diverse bodily systems. The rising prevalence of infectious conditions can be linked to heightened international travel and the emergence of antimicrobial resistance, making infection management more challenging. Enzyme-linked immunosorbent assay (ELISA) testing proves beneficial for infectious disorders by enabling precise identification and measurement of particular antigens or antibodies associated with the infection, thereby assisting in diagnosis, tracking disease advancement, and assessing treatment efficacy. As an illustration, in February 2024, data released by the World Health Organization, a Switzerland-based intergovernmental public health entity, showed that a total of 58114 measles (a highly communicable viral illness) cases were reported in the European Region in 2023, significantly up from 941 cases in 2022. Consequently, the increasing occurrence of infectious diseases is fueling the expansion of the enzyme-linked immunosorbent assay testing market.

How Is The Enzyme-Linked Immunosorbent Assay Testing Market Divided Into Its Major Segments?

The enzyme-linked immunosorbent assay testing market covered in this report is segmented –

1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)

2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users

Subsegments:

1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA

2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA

3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA

4) By Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA): Multiplex ELISA (Multi-Analyte ELISA), Portable / Point-of-Care (POC) ELISA, Microfluidic-Based ELISA, Quantitative Portable ELISA, Qualitative Portable ELISA

5) By Competitive Enzyme-Linked Immunosorbent Assay (ELISA): Direct Competitive ELISA, Indirect Competitive ELISA, Quantitative Competitive ELISA, Qualitative Competitive ELISA

Which Trends Are Influencing The Enzyme-Linked Immunosorbent Assay Testing Market?

Leading firms within the enzyme-linked immunosorbent assay testing market are concentrating on expanding their product range via innovations, including advanced novel enzyme-linked immunosorbent assay (ELISA) kits, with the goal of improving diagnostic precision and addressing various research and clinical requirements. These novel Enzyme-Linked Immunosorbent Assay (ELISA) kits represent enhanced iterations of ELISA tests, providing superior accuracy, sensitivity, and ease of use in the detection and quantification of biomarkers. An example is Charles River Laboratories, a US-based pharmaceutical company, which in February 2023, launched a new enzyme-linked immunosorbent assay (ELISA) kit specifically designed for identifying and measuring residual host cell proteins (HCP) found in CHO-based biotherapeutics. This groundbreaking kit employs avian immunoglobulin Y (IgY) antibodies derived from specific pathogen-free (SPF) chicken eggs, delivering heightened sensitivity and specificity, evidenced by detection limits reaching 0.1 ng/mL and an antibody coverage of 90%. The introduction of this kit intends to elevate quality control processes in biopharmaceutical development, thereby guaranteeing the safety and effectiveness of emerging therapies, and offers clients flexible usage, either autonomously or with assistance from Charles River’s specialists.

Who Are The Prominent Organizations Shaping The Enzyme-Linked Immunosorbent Assay Testing Market?

Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

Read the full enzyme-linked immunosorbent assay testing market report here:

https://www.thebusinessresearchcompany.com/report/enzyme-linked-immunosorbent-assay-testing-global-market-report

Which Region Is Forecast To Lead The Enzyme-Linked Immunosorbent Assay Testing Market In Terms Of Market Size?

North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2025. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Enzyme-Linked Immunosorbent Assay Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19417&type=smp

Browse Through More Reports Similar to the Global Enzyme-Linked Immunosorbent Assay Testing Market 2026, By The Business Research Company

Aerogel Global Market Report

https://www.thebusinessresearchcompany.com/report/aerogel-global-market-report

Coffee Capsule Global Market Report

https://www.thebusinessresearchcompany.com/report/coffee-capsule-global-market-report

Empty Capsules Global Market Report

https://www.thebusinessresearchcompany.com/report/empty-capsules-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795